嚢胞性線維症(CF)治療の世界市場予測

◆英語タイトル:Global Cystic Fibrosis Market – Estimation & Forecast, 2013-2022
◆商品コード:MRF704005
◆発行会社(調査会社):Market Research Future
◆発行日:2017年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(印刷不可)USD4,450 ⇒換算¥489,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Introduction The global cystic fibrosis market was valued at $ 3145.7 million in 2015 and expected to reach at $ 8852.2 million by 2022 at a CAGR of 13.5 % during the forecast period. The major factors responsible for the growth of global cystic fibrosis market are; development of new drugs and therapies, financial support from interest organizations in research and development of cystic fibrosis drugs and others. The growth barriers are high cost of the drugs and treatment among others.

The market is majorly categorized on the basis of treatment method types which is further segmented into medication, devices and other treatments and geographic regions. Globally, North America holds the largest market share of global cystic fibrosis market, registering 43.2 % in 2015.
The scope of Global Cystic fibrosis market study includes the market value, market size and a detailed analysis of vendor products and strategies.
Key Players
The leading players of the Global Cystic fibrosis market are AbbVie, Allergan Plc, Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, Gilead Sciences, Novartis AG, Pharmaxis Ltd., PTC Therapeutics, Vertex Pharmaceuticals Incorporated and others.

Study Objectives of Cystic Fibrosis Market Development and Demand Forecast to 2022 Market
 To provide insights about factors, influencing and affecting the market growth
 To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
 To provide historically and forecast revenue of the market segments based on type, and sub-segment for Global Cystic fibrosis market
 To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
 To provide economic factors that influence the Global Cystic fibrosis market

Target Audience
• Cystic fibrosis companies
• Hospitals & Clinics
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• On the basis of types, medication segment holds largest market share of global cystic fibrosis market, registering 76.4 % of total market in 2015.
• US holds 66.48 % market share of North America cystic fibrosis Market and is expected to reach $ 2556.7 million by 2022 from $ 903.7million in 2015.

The reports also cover country level analysis:
• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

【レポートの目次】

1 Introduction 8
1.1 Definition 8
1.2 Scope of Study 8
1.3 Research Objective 8
1.4 Assumptions & Limitations 9
1.4.1 Assumptions 9
1.4.2 Limitations 9
1.5 Market Structure 9
2 Research Methodology 10
2.1 Research Process 10
2.2 Primary Research 11
2.3 Secondary Research 11
3 Market Dynamics 12
3.1 Drivers 12
3.1.1 Introduction 12
3.1.2 Development of New Drugs and Therapies 12
3.1.3 Financial Support from CFF in Research and Development of CF Drugs. 12
3.2 Restraints 13
3.2.1 Introduction 13
3.2.2 High Cost of the Drugs and Treatment 13
3.3 Opportunities 13
3.4 Challenges 14
3.4.1 Awareness About the Rare Disease in the Developing Countries 14
4 Market Factor Analysis 15
4.1 Porter’s Five Forces Model 15
4.1.1 Bargaining Power of Suppliers 15
4.1.2 Bargaining Power of Buyers 15
4.1.3 Threat of New Entrants 16
4.1.4 Threat of Substitutes 16
4.1.5 Intensity of Rivalry 16
5 Cystic Fibrosis Market, By Treatment Method 17
5.1 Introduction 17
5.2 Medication 18
5.3 Devices 19
5.4 Other Treatments 20
6 Cystic Fibrosis Market, By Regions 22
6.1 Introduction 22
6.2 North America 24
6.3 Europe 27
6.4 Asia-Pacific 33
6.5 Middle East & Africa 38
7 Company Share Analysis 41
8 Company Profile 43
8.1 AbbVie 43
8.1.1 Company Overview 43
8.1.2 Product Overview 43
8.1.3 Financials 44
8.1.4 Key Developments 45
8.2 Allergan Plc 46
8.2.1 Company Overview 46
8.2.2 Product Overview 46
8.2.3 Financials 46
8.2.4 Key Developments 47
8.3 Chiesi Farmaceutici S.p.A. 48
8.3.1 Company Overview 48
8.3.2 Product/Business Segment Overview 48
8.3.3 Financials 48
8.3.4 Key Developments 49
8.4 F. Hoffmann-La Roche AG 50
8.4.1 Company Overview 50
8.4.2 Product/Business Segment Overview 50
8.4.3 Financials 50
8.4.4 Key Developments 51
8.5 Gilead Sciences 52
8.5.1 Company Overview 52
8.5.2 Product Overview 52
8.5.3 Financials 52
8.5.4 Key Developments 52
8.6 Novartis AG 53
8.6.1 Company Overview 53
8.6.2 Product Overview 53
8.6.3 Financials 53
8.6.4 Key Developments 54

8.7 Pharmaxis Ltd. 55
8.7.1 Company Overview 55
8.7.2 Product Overview 55
8.7.3 Financials 55
8.7.4 Key Developments 56
8.8 PTC Therapeutics 57
8.8.1 Company Overview 57
8.8.2 Product Overview 57
8.8.3 Financials 57
8.8.4 Key Developments 58
8.9 Vertex Pharmaceuticals Incorporated 59
8.9.1 Company Overview 59
8.9.2 Product/Business Segment Overview 59
8.9.3 Financials 59

TABLE 1 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 18
TABLE 2 GLOBAL CYSTIC FIBROSIS MEDICATION MARKET, BY REGION, 2013-2027 ($MILLION) 19
TABLE 3 GLOBAL CYSTIC FIBROSIS DEVICES MARKET, BY REGION, 2013-2027 ($MILLION) 20
TABLE 4 GLOBAL CYSTIC FIBROSIS OTHER TREATMENTS MARKET, BY REGION, 2013-2027 ($MILLION) 21
TABLE 5 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2013-2022 ($MILLION) 23
TABLE 6 NORTH AMERICA CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION) 24
TABLE 7 NORTH AMERICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 25
TABLE 8 U.S. CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 26
TABLE 9 CANADA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 26
TABLE 10 EUROPE CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION) 28
TABLE 11 EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 29
TABLE 12 GERMANY CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 29
TABLE 13 FRANCE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 29
TABLE 14 U.K. CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 30
TABLE 15 ITALY CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 30
TABLE 16 SPAIN CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 31
TABLE 17 REST OF WESTERN EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 31
TABLE 18 EASTERN EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 32
TABLE 19 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY COUNTRY, 2013-2022 ($MILLION) 34
TABLE 20 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 35
TABLE 21 AUSTRALIA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 35
TABLE 22 JAPAN CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 35
TABLE 23 CHINA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 36
TABLE 24 INDIA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 36
TABLE 25 REPUBLIC OF KOREA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 37
TABLE 26 REST OF ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 37
TABLE 27 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY REGION, 2013-2022 ($MILLION) 38
TABLE 28 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 39
TABLE 29 MIDDLE EAST CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 40
TABLE 30 AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2013-2022 ($MILLION) 40
TABLE 31 CHIESI FARMACEUTICI S.P.A.: KEY DEVELOPMENTS 49
TABLE 32 VERTEX PHARMACEUTICALS INCORPORATED: KEY DEVELOPMENTS 60



FIGURE 1 RESEARCH PROCESS OF MRFR 10
FIGURE 2 PORTER'S 5 FORCES ANALYSIS OF GLOBAL CYSTIC FIBROSIS MARKET 15
FIGURE 3 GLOBAL CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION) 17
FIGURE 4 GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, 2015 (%) 22
FIGURE 5 NORTH AMERICA CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%) 24
FIGURE 6 NORTH AMERICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION) 25
FIGURE 7 EUROPE CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%) 27
FIGURE 8 EUROPE CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION) 28
FIGURE 9 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY COUNTRY, 2015 (%) 33
FIGURE 10 ASIA-PACIFIC CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 % 2022 ($MILLION) 34
FIGURE 11 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY REGION, 2015 (%) 38
FIGURE 12 MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET, BY TREATMENT METHOD, 2015 & 2022 ($MILLION) 39
FIGURE 13 CYSTIC FINROSIS MARKET SHARE, 2016 (%) 41
FIGURE 14 ABBVIE: RECENT FINANCIAL 44
FIGURE 15 ABBVIE: BUSINESS REVENUE, 2015 (%) 44
FIGURE 16 ABBVIE: GEOGRAPHIC REVENUE, 2015 (%) 45
FIGURE 17 ALLERGAN: RECENT FINANCIAL 46
FIGURE 18 ALLERGAN: BUSINESS REVENUE, 2015 (%) 47
FIGURE 19 ALLERGAN: GEOGRAPHIC REVENUE, 2015 (%) 47
FIGURE 20 CHIESI FARMACEUTICI S.P.A.: RECENT FINANCIALS 48
FIGURE 21 F. HOFFMANN-LA ROCHE AG.: RECENT FINANCIALS 50
FIGURE 22 F. HOFFMANN-LA ROCHE AG.: BUSINESS REVENUE 51
FIGURE 23 GILEAD SCIENCES: RECENT FINANCIAL 52
FIGURE 24 NOVARTIS AG: RECENT FINANCIALS 53
FIGURE 25 NOVARTIS AG: BUSINESS REVENUE, 2015 (%) 54
FIGURE 26 NOVARTIS AG: GEOGRAPHIC REVENUE, 2015 (%) 54
FIGURE 27 PHARMAXIS LTD: RECENT FINANCIALS 55
FIGURE 28 PTC THERAPEUTICS: RECENT FINANCIALS 57
FIGURE 29 PTC THERAPEUTICS: GEOGRAPHICAL REVENUE (%) 58
FIGURE 30 PTC THERAPEUTICS: R&D EXPENSES, 2015 (%) 58
FIGURE 31 VERTEX PHARMACEUTICALS INCORPORATED: RECENT FINANCIALS 59
FIGURE 32 VERTEX PHARMACEUTICALS INCORPORATED: BUSINESS REVENUE 60
FIGURE 33 VERTEX PHARMACEUTICALS INCORPORATED: GEOGRAPHICAL REVENUE 60



【レポートのキーワード】

嚢胞性線維症(CF)

★調査レポート[嚢胞性線維症(CF)治療の世界市場予測] (コード:MRF704005)販売に関する免責事項を必ずご確認ください。
★調査レポート[嚢胞性線維症(CF)治療の世界市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆